 | Up a level |
2020
Kramer, R., Mentzer, D., Erdmann, M., Knauss, S., Broeckelmann, P. J., Hassel, J. C., Ugurel, S., Pavel, M., Nickel, F. T., Landendinger, M., Fuchs, F., Meidenbauer, N., Jefremow, A., Manger, B., Gutzmer, R., Loquai, C., Kaehler, K., Zimmer, L., Berking, C., Keller-Stanislawski, B. and Heinzerling, L. (2020). SERIO - Side Effect Registry Immuno-Oncology Side Effect Registry for rare, severe and complex Side Effects of Immunotherapy. J. Dtsch. Dermatol. Ges., 18. S. 14 - 16. HOBOKEN: WILEY. ISSN 1610-0387
Livingstone, E., Zaremba, A., Horn, S., Ugurel, S., Casalini, B., Schlaak, M., Hassel, J. C., Herbst, R., Utikal, J. S., Weide, B., Gutzmer, R., Meier, F., Koelsche, C., Hadaschik, E., Sucker, A., Reis, H., Merkelbach-Bruse, S., Siewert, M., Sahm, F., von Deimling, A., Cosgarea, I., Zimmer, L., Schadendorf, D., Schilling, B. and Griewank, K. G. (2020). GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma. Br. J. Dermatol., 183 (5). S. 928 - 940. HOBOKEN: WILEY. ISSN 1365-2133
Zaremba, A., Martaki, A., Salzmann, M., Baroudjian, B., Sachse, M. M., Gesierich, A., Reinhardt, L., Meier, F., Hassel, J. C., Ugurel, S., Roesch, A., Schadendorf, D., Livingstone, E., Broeckelmann, P., Kramer, R., Heinzerling, L. and Zimmer, L. (2020). Agranulocytosis with Immune Checkpoint-Blockade - a retrospective, multicenter Evaluation. J. Dtsch. Dermatol. Ges., 18. S. 15 - 17. HOBOKEN: WILEY. ISSN 1610-0387
2010
Hassel, J. C., Sucker, A., Edler, L., Kurzen, H., Moll, I., Stresemann, C., Spieth, K., Mauch, C., Rass, K., Dummer, R. and Schadendorf, D. (2010). MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. Br. J. Cancer, 103 (6). S. 820 - 827. LONDON: NATURE PUBLISHING GROUP. ISSN 1532-1827